Cargando…

Cytokine Signatures in Psoriatic Arthritis Patients Indicate Different Phenotypic Traits Comparing Responders and Non-Responders of IL-17A and TNFα Inhibitors

This study aimed to explore the dynamic interactions between 32 cytokines and biomarkers in Psoriatic Arthritis (PsA) patients to compare cytokine signatures of treatment responders and non-responders. Biomarkers were measured before and after four months of treatment in 39 PsA patients initiating e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skougaard, Marie, Ditlev, Sisse Bolm, Søndergaard, Magnus Friis, Kristensen, Lars Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093817/ https://www.ncbi.nlm.nih.gov/pubmed/37047315 http://dx.doi.org/10.3390/ijms24076343

Ejemplares similares

Four emerging immune cellular blood phenotypes associated with disease duration and activity established in Psoriatic Arthritis
por: Skougaard, Marie, et al.
Publicado: (2022)

Psoriatic Arthritis That Responded Dramatically When Infliximab Was Switched to Adalimumab
por: Ohshima, Yuichiro, et al.
Publicado: (2013)

Choosing the Appropriate Target for the Treatment of Psoriatic Arthritis: TNFα, IL-17, IL-23 or JAK Inhibitors?
por: Gialouri, Chrysoula G., et al.
Publicado: (2022)

Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis
por: Gladman, Dafna, et al.
Publicado: (2020)

The Clinical Significance of Simultaneous IL-17A and IL-17F Blockade in Psoriasis Non-Responding to Anti-IL17A Therapy
por: Kokolakis, Georgios, et al.
Publicado: (2022)

The human transmembrane mucin MUC17 responds to TNFα by increased presentation at the plasma membrane
por: Schneider, Hannah, et al.
Publicado: (2019)

A Case of Recalcitrant Psoriatic Arthritis to TNF Inhibitors Improved After Administration of Secukinumab, an IL-17A Inhibitor
por: Pelechas, Eleftherios, et al.
Publicado: (2017)

Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis
por: Rahmati, Sara, et al.
Publicado: (2020)

Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies
por: Sánchez-Rodríguez, Guillermo, et al.
Publicado: (2023)

Network meta-analysis and cost per responder of targeted Immunomodulators in the treatment of active psoriatic arthritis
por: Strand, Vibeke, et al.
Publicado: (2018)

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
por: Blauvelt, Andrew, et al.
Publicado: (2018)

A potential inflammatory role of IL-31 in psoriatic arthritis: A correlation with Th17 cytokine profile
por: Bautista-Herrera, LA, et al.
Publicado: (2020)

The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis
por: Vecellio, Matteo, et al.
Publicado: (2021)

Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis
por: Thomson, Ty M., et al.
Publicado: (2015)

Cost per responder of TNF-α therapies in Germany
por: Gissel, Christian, et al.
Publicado: (2013)

Cytokines in Systemic Lupus Erythematosus—Focus on TNF-α and IL-17
por: Richter, Patricia, et al.
Publicado: (2023)

Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?
por: Yang, Xu, et al.
Publicado: (2016)

Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease
por: Gisondi, Paolo, et al.
Publicado: (2022)

Dual inhibition of IL-17A and IL-17F in psoriatic disease
por: Iznardo, Helena, et al.
Publicado: (2021)

The Th17/IL-23 Axis and Natural Immunity in Psoriatic Arthritis
por: Maeda, Shinji, et al.
Publicado: (2012)

Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy
por: McGeough, Cathy M., et al.
Publicado: (2011)

From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis
por: Silvagni, Ettore, et al.
Publicado: (2021)

Ex vivo cytokine production in psoriatic disease: Towards specific signatures in cutaneous psoriasis and peripheral psoriatic arthritis
por: Larid, Guillaume, et al.
Publicado: (2022)

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
por: Baranauskaite, Asta, et al.
Publicado: (2011)

Review of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders
por: D’Angelo, Salvatore, et al.
Publicado: (2017)

Regulatory T cells enhance Th17 migration in psoriatic arthritis which is reversed by anti-TNF
por: Nguyen, Dao X., et al.
Publicado: (2021)

Elevated Circulating TNF-α in Fat-Free Mass Non-Responders Compared to Responders Following Exercise Training in Older Women
por: Fisher, Gordon, et al.
Publicado: (2014)

CXCL4 is a novel inducer of human Th17 cells and correlates with IL‐17 and IL‐22 in psoriatic arthritis
por: Affandi, Alsya J., et al.
Publicado: (2018)

To respond or not to respond: exploring empathy-related psychological and structural brain differences between placebo analgesia responders and non-responders
por: Hartmann, Helena, et al.
Publicado: (2023)

Respondent
por: Mitchell, Samuel A.
Publicado: (1992)

Establishment of an Intradermal Ear Injection Model of IL-17A and IL-36γ as a Tool to Investigate the Psoriatic Cytokine Network
por: Kluwig, David, et al.
Publicado: (2021)

To respond or not to respond, the recurring question in plant mechanosensitivity
por: Leblanc-Fournier, Nathalie, et al.
Publicado: (2014)

Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis
por: Sakkas, Lazaros I., et al.
Publicado: (2019)

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
por: McGonagle, Dennis G, et al.
Publicado: (2019)

IL-17 producing mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis
por: Noordenbos, Troy, et al.
Publicado: (2011)

A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity
por: Terashima, Asuka, et al.
Publicado: (2008)

The effects of IL-17/IL-17R inhibitors on atherosclerosis in psoriasis and psoriatic arthritis: A protocol for systematic review and meta analysis
por: Liu, Ningyuan, et al.
Publicado: (2021)

Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
por: van Baarsen, Lisa GM, et al.
Publicado: (2014)

Increase of Circulating Monocyte–Platelet Conjugates in Rheumatoid Arthritis Responders to IL-6 Blockage
por: Mariscal, Anaís, et al.
Publicado: (2022)

Treating psoriatic arthritis: how effective are TNF antagonists?
por: Gottlieb, Alice B, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_jlo4gtd0g300c8rjsc124gb7rv